|
PATENTS
Biogen Can't Escape Amended Antitrust Suit Over MS Drug
By Dorothy Atkins
Biogen Inc. must face health plans' claims that it bribed pharmacy benefit managers to stifle generics competition for its multiple sclerosis drug Tecfidera, after an Illinois federal judge found Wednesday that the plans' latest amended complaint in their consolidated antitrust litigation corrects her prior concerns with the pleadings.
Opinion attached |
Read full article »
| Save to favorites »
COPYRIGHTS & TRADEMARKS
TRADE SECRETS
RIGHTS OF PUBLICITY
ROYALTIES
PEOPLE
EXPERT ANALYSIS
LEGAL INDUSTRY
Bondi Elevates Pa. US Atty Amid Appointments Scrutiny
By Matthew Santoni
The first assistant U.S. attorney for the Western District of Pennsylvania is being retained and elevated to full U.S. attorney, Attorney General Pamela Bondi announced Thursday, though the appointment will have to remain temporary or he could face the same questions about his appointment as other top prosecutors in President Donald Trump's administration.
Read full article »
| Save to favorites »
|